Here are the editors' top picks for the week ended Dec. 28.
Of Mice Not Men: Tracking mosquito viruses; CRISPR-ing obesity and tumors
In this week's column, scientists looked to mosquitoes' stomachs to track the transmission of viruses, an Alzheimer's protein was found in contaminated brain tissue extracts, and CRISPR mitigated obesity and chemotherapy resistance in mice.
Capitol Checkup: Both sides want speedy ACA appeal; FDA shutdown may go to 2019
Both sides in the legal battle over the constitutionality of the Affordable Care Act want the case to promptly move forward to an appeal; meanwhile, the head of the U.S. Food and Drug Administration tried to reassure Americans during the shutdown.
EU agency recommends 84 new medicines in 2018; reviews heart drugs with impurity
The European Medicines Agency recommended 84 new medicines for marketing authorization in 2018 and initiated the review of a hypertension drug after finding traces of a potential cancer-causing compound.
Junshi stock surges to HK$23.75 per share in Hong Kong debut
The Shanghai-based company in December received approval to produce China's first homemade PD-1 class of checkpoint inhibitors.
Medicaid agency approves work requirement programs for Michigan, Maine
The Centers for Medicare and Medicaid Services has approved work requirement waivers for Maine and Michigan, increasing the number of states to have work requirement programs approved to seven.
Medicare agency finalizes changes to shared savings program for provider groups
The Centers for Medicare and Medicaid Services finalized the agency's restructuring of the accountable care organization shared savings program. The agency also increased certain savings rates from their levels in the August proposed rule.
US price watchdog: Novartis' gene therapy is better value than Biogen rival
The Institute for Clinical and Economic Review has found that a new gene therapy from Novartis AG is more cost-effective than Biogen Inc.'s Spinraza in treating a rare, debilitating infant disease called spinal muscular atrophy.